The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include details about how Medicare Part B drugs and renegotiation processes will be ...
In his first month as president, Donald Trump and his administration have gleefully dismantled many of former President Joe Biden’s initiatives. However, there has been one notable exception: the ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the program continues. In the two years since the first case challenging the program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results